A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 4, 1998, Pages 375-383

  Stainer, C J ^a   Miflin, G ^a,b   Anderson, S ^a   Davy, B ^a   McQuaker, I G ^a   Russell, N H ^a,b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031664932     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.375     Document Type: Review

References (34)

1. Andrews, R.G., Singer, J.W. & Bernstein, I.D. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986.
2. Bender, J.G., Unverzagt, K.L., Walker, D.E., et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591, 1991.
3. Berenson, R.J., Bensinger, W.I., Hill, R.S., et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991.
4. Vescio, R.A., Hong, C.H., Cao, J., et al. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994.
5. Berenson, R.J., Andrews, R.G., Bensinger, W.I., et al. Selection of CD34 marrow cells for autologous marrow transplantation. Hematol. Oncol. Ann. 2:78, 1994.
6. Lambrechts, A.C., Hupkes, P.E., Dorssers, L.C.J., et al. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 82:2510, 1993.
7. Bird, J.M., Bloxham, D., Samson, D., et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br. J. Haematol. 88:110, 1994.
8. Brugger, W., Bross, K. & Glatt, M. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
9. Gribben, J.G., Freedman, A.S., Woo, S.D., et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991.
10. Gribben, J.G., Neuberg, N., Barber, M., et al. Detection of residual lymphoma cells by polymerase chain in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994.
11. McQuaker, I.G., Haynes, A.P., Anderson, S., et al. Engraftment and molecular monitoring of CD34+ peripheral-blood stem-cell transplants for follicular lymphoma: A pilot study. J. Clin. Oncol. 15:2288, 1997.
12. Craig, J.I.O., Langlands, K., Parker, A.C., et al. Molecular detection of tumor contamination of peripheral blood stem cell harvests. Exp. Hematol. 22:898, 1994.
13. Tricot, G., Gazzit, Y., Jagannath, S., et al. CD34+THY+ LIN-peripheral blood stem cells (PBSC) effect timely trilineage engraftment in multiple myeloma (MM). Blood 86:293a, 1995.
14. McNeice, I., Briddell, R., Stoney, G., et al. Large scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J. Hematother. 6:5, 1997.
15. Gorin, N.-C., Lopez, M., Laporte, J.-P., et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 85:1647, 1995.
16. Farley, T.J., Ahmed, T., Fitzgerald, M., et al. Optimization of CD34+ cell selection using immunomagnetic beads: Implications for use in cryopreserved peripheral blood stem cell collections. J. Hematother. 6:53, 1997.
17. Hohaus, S., Pforsich, M., Murea, S., et al. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer. Br. J Haematol. 97:881, 1997.
18. Lane, T.A., Law, P., Maruyana, M., et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995.
19. Schiller, G., Vescio, R., Freytes, C., et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995.
20. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
21. Haynes, A.P., Hunter, A., McQuaker, G., et al. Engraftment characteristics of peripheral blood stem cells mobilized with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant. 16:359, 1995.
22. McQuaker, I.G., Haynes, A.P., Stainer, C., et al. Stem cell mobilization in resistant or relapsed lymphoma: Superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br. J. Haematol. 98:228, 1997.
23. Miflin, G., Charley, C., Stainer, C., et al. Stem cell mobilization in normal donors for allogeneic transplantation: Analysis of safety and factors affecting efficacy. Br. J. Haematol. 95:345, 1996.
24. Sutherland, D.R., Stewart, A.K., & Keating, A. CD34 antigen: Molecular features and potential clinical applications. Stem Cells 11:50, 1993.
25. Sutherland, D.R., Anderson, L., Keeney, M., et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J. Hematother. 5:213, 1996.
26. Bjorkstrand, B., Sundman-Engberg, B., Christensson, B., et al. A comparison of Isolex 300i and CEPRATE SC devices for CD34+ cell selection of autologous blood and bone marrow grafts. J. Hematother. 6:417, 1997.
27. Marolleau, J.P., Brice, P., Cortivo, L., et al. CD34+ selection by immunomagnetic selection (Isolex 300) for patients with malignancies. Blood (Suppl. 1)88(110a):427, 1996.
28. Shpall, E.J., Gehling, U., Cagnoni, P., et al. Isolation of CD34-positive hematopoietic progenitor cells. Immunomethods 5:197, 1994.
29. Mahe, B., Milpied, N., Hermouet, S., et al. G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphoma. Br. J. Haematol. 92:263, 1996.
30. Watts, M.J., Sullivan, A.M., Ings, S.J., et al. Evaluation of clinical scale CD34+ cell purification: Experience of 71 immunoaffinity column procedures. Bone Marrow Transplantat. 20:157, 1997.
31. To, L.B., Dyson, P.G., & Hughes, T.P. CD34+ selection of mobilized allogeneic stem cell products using the Isolex 300. J. Hematother. 6:404, 1997.
32. Clarke, E., Potter, M.N., Oakhill, A., et al. A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: Clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplantat. 20:599, 1997.
33. Kernan, N.A., Collins, N.H., Juliano, L., et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-hose disease. Blood 68:770, 1986.
34. Aversa, R, Tabilio, A., Terenzi, A., et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 1994.